PHARMACYTE BIOTECH, INC. Cash, Period Increase (Decrease)
PHARMACYTE BIOTECH, INC. (PMCB) reported Cash, Period Increase (Decrease) of $2.20 million for the 9-month period ending 2021-01-31, per its 10-Q filed 2021-03-12.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2021-03-12
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for the quarter ending 2021-01-31 was -$626.43K, a 744.60% decline year-over-year.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for the quarter ending 2020-10-31 was $1.55M.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for the quarter ending 2020-07-31 was $1.27M.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for the quarter ending 2020-04-30 was $752.62K.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for fiscal 2020 was $379.61K.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for fiscal 2019 was -$544.54K.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for fiscal 2018 was -$2.40M, a 255.79% decline from fiscal 2017.
- PHARMACYTE BIOTECH, INC. cash, period increase (decrease) for fiscal 2017 was $1.54M.
| Period end | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 3 month as first filed | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2021-01-31 | -$626.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-12 | $924.38K derived: sum of 2 quarters · filed 2021-03-12 | $2.20M 10-Q · filed 2021-03-12 | $2.95M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-10-31 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-11 | $2.82M 10-Q · filed 2020-12-11 | $3.58M derived: sum of 3 quarters · filed 2020-12-11 | $3.67M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-07-31 | $1.27M 10-Q · filed 2020-09-11 | $2.02M derived: sum of 2 quarters · filed 2020-09-11 | $2.12M derived: sum of 3 quarters · filed 2021-03-12 | $1.84M derived: sum of 4 quarters · filed 2021-03-12 | |
| 2020-04-30 | $752.62K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $849.80K derived: sum of 2 quarters · filed 2021-03-12 | $567.11K derived: sum of 3 quarters · filed 2021-03-12 | $379.61K 10-K · filed 2020-08-13 | |
| 2020-01-31 | $97.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-12 | -$185.51K derived: sum of 2 quarters · filed 2021-03-12 | -$373.01K 10-Q · filed 2021-03-12 | -$557.22K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-10-31 | -$282.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-11 | -$470.19K 10-Q · filed 2020-12-11 | -$654.40K derived: sum of 3 quarters · filed 2020-12-11 | -$862.36K derived: sum of 4 quarters · filed 2020-12-11 | |
| 2019-07-31 | -$187.50K 10-Q · filed 2020-09-11 | -$371.71K derived: sum of 2 quarters · filed 2020-09-11 | -$579.67K derived: sum of 3 quarters · filed 2020-09-11 | -$1.50M derived: sum of 4 quarters · filed 2020-09-11 | |
| 2019-04-30 | -$184.21K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | -$392.16K derived: sum of 2 quarters · filed 2020-08-13 | -$1.32M derived: sum of 3 quarters · filed 2020-08-13 | -$544.54K 10-K · filed 2020-08-13 | |
| 2019-01-31 | -$207.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-13 | -$1.13M derived: sum of 2 quarters · filed 2020-03-13 | -$360.34K 10-Q · filed 2020-03-13 | -$808.38K derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-10-31 | -$923.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-23 | -$152.38K 10-Q · filed 2019-12-23 | -$600.43K derived: sum of 3 quarters · filed 2019-12-23 | -$1.77M derived: sum of 4 quarters · filed 2019-12-23 | |
| 2018-07-31 | $771.48K 10-Q · filed 2018-09-12 | $323.44K derived: sum of 2 quarters · filed 2019-08-13 | -$850.83K derived: sum of 3 quarters · filed 2019-08-13 | -$2.18M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-04-30 | -$448.05K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | -$1.62M derived: sum of 2 quarters · filed 2019-08-13 | -$2.95M derived: sum of 3 quarters · filed 2019-08-13 | -$2.40M 10-K · filed 2019-08-13 | |
| 2018-01-31 | -$1.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | -$2.50M derived: sum of 2 quarters · filed 2019-03-14 | -$1.96M 10-Q · filed 2019-03-14 | -$956.42K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-10-31 | -$1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | -$782.12K 10-Q · filed 2018-12-14 | $217.84K derived: sum of 3 quarters · filed 2018-12-14 | $1.13M derived: sum of 4 quarters · filed 2018-12-14 | |
| 2017-07-31 | $543.45K 10-Q · filed 2018-09-12 | $814.12K 10-Q · filed 2017-09-13 | $1.54M derived: sum of 2 quarters · filed 2018-09-12 | $2.46M derived: sum of 3 quarters · filed 2018-09-12 | $1.67M derived: sum of 4 quarters · filed 2018-09-12 |
| 2017-04-30 | $999.96K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | $1.91M derived: sum of 2 quarters · filed 2018-07-20 | $1.12M derived: sum of 3 quarters · filed 2018-07-20 | $1.54M 10-K · filed 2018-07-20 | |
| 2017-01-31 | $912.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $124.45K derived: sum of 2 quarters · filed 2018-03-19 | $543.45K 10-Q · filed 2018-03-19 | -$399.71K derived: sum of 4 quarters · filed 2018-03-19 | |
| 2016-10-31 | -$788.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-14 | -$369.21K 10-Q · filed 2017-12-14 | -$1.31M derived: sum of 3 quarters · filed 2017-12-14 | -$760.82K derived: sum of 4 quarters · filed 2017-12-14 | |
| 2016-07-31 | $418.99K 10-Q · filed 2017-09-13 | -$524.17K derived: sum of 2 quarters · filed 2017-09-13 | $27.39K derived: sum of 3 quarters · filed 2017-09-13 | -$570.38K derived: sum of 4 quarters · filed 2017-09-13 | |
| 2016-04-30 | -$943.16K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | -$391.61K derived: sum of 2 quarters · filed 2017-07-27 | -$989.38K derived: sum of 3 quarters · filed 2017-07-27 | -$778.91K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $551.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-13 | -$46.22K derived: sum of 2 quarters · filed 2017-03-13 | $164.25K 10-Q · filed 2017-03-13 | $1.91M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-10-31 | -$597.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-02 | -$387.31K 10-Q · filed 2016-12-02 | $1.35M derived: sum of 3 quarters · filed 2016-12-02 | $1.16M derived: sum of 4 quarters · filed 2016-12-02 | |
| 2015-07-31 | $210.46K 10-Q · filed 2016-09-06 | $1.95M derived: sum of 2 quarters · filed 2016-09-06 | $1.76M derived: sum of 3 quarters · filed 2016-09-06 | $13.26K derived: sum of 4 quarters · filed 2016-09-06 | |
| 2015-04-30 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $1.54M derived: sum of 2 quarters · filed 2016-07-29 | -$197.20K derived: sum of 3 quarters · filed 2016-07-29 | -$916.73K 10-K · filed 2016-07-29 | |
| 2015-01-31 | -$196.19K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-03-08 | -$1.94M derived: sum of 2 quarters · filed 2016-03-08 | -$2.66M 10-Q · filed 2016-03-08 | $93.92K derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-10-31 | -$1.74M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | -$2.46M 10-Q/A · filed 2016-01-19 | $290.11K derived: sum of 3 quarters · filed 2016-07-29 | $758.41K derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-07-31 | -$719.53K 10-Q/A · filed 2016-01-19 | $2.03M derived: sum of 2 quarters · filed 2016-07-29 | $2.50M derived: sum of 3 quarters · filed 2016-07-29 | $2.69M derived: sum of 4 quarters · filed 2016-07-29 | |
| 2014-04-30 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $3.22M derived: sum of 2 quarters · filed 2016-07-29 | $3.41M derived: sum of 3 quarters · filed 2016-07-29 | $3.42M 10-K · filed 2016-07-29 | |
| 2014-01-31 | $468.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $658.86K derived: sum of 2 quarters · filed 2014-03-17 | $665.59K 10-Q · filed 2014-03-17 | $831.56K derived: sum of 4 quarters · filed 2016-01-19 | |
| 2013-10-31 | $190.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $197.29K 10-Q · filed 2013-12-16 | $363.26K derived: sum of 3 quarters · filed 2016-01-19 | $373.90K derived: sum of 4 quarters · filed 2016-01-19 | |
| 2013-07-31 | $6.74K 10-Q · filed 2014-09-15 | $172.70K derived: sum of 2 quarters · filed 2016-01-19 | $183.34K derived: sum of 3 quarters · filed 2016-01-19 | ||
| 2013-04-30 | $165.97K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | $176.61K derived: sum of 2 quarters · filed 2016-01-19 | $183.58K 10-K/A · filed 2016-01-19 | ||
| 2013-01-31 | $10.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $17.61K 10-Q · filed 2014-03-17 | |||
| 2012-10-31 | $6.97K 10-Q · filed 2013-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |